| Hospice Of Kona 75-5925 Walua Road, Suite 101, Kailua Kona, HI, 96740 | |
| (808) 324-7700 |
News Archive
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
New research has found that modern lifestyle habits may play a bigger role than food alone, when it comes to tooth decay.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
During her three-year battle with breast cancer, my wife, Leslie, graciously endured multiple rounds of horrifically toxic treatment to eke out more time with our two young children.
Rickets is a disease of the growing bones among children that is caused due to deficiency of Vitamin D mainly due to lack of sunlight exposure. It was most commonly seen during the Victorian era due to smog and lack of exposure to sunlight among the children in the cities
› Verified 3 days ago
| Name | Hospice Of Kona |
|---|---|
| Location | 75-5925 Walua Road, Suite 101, Kailua Kona, Hawaii |
| Hospice ID | 121505 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 010 |
News Archive
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
New research has found that modern lifestyle habits may play a bigger role than food alone, when it comes to tooth decay.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
During her three-year battle with breast cancer, my wife, Leslie, graciously endured multiple rounds of horrifically toxic treatment to eke out more time with our two young children.
Rickets is a disease of the growing bones among children that is caused due to deficiency of Vitamin D mainly due to lack of sunlight exposure. It was most commonly seen during the Victorian era due to smog and lack of exposure to sunlight among the children in the cities
› Verified 3 days ago
| NPI Number | 1356409270 |
| Organization Name | Hospice Of Kona, Inc. |
| Address | 75-5925 Walua Road Kailua Kona, Hawaii, 96740 |
| Phone Number | (808)324-7700 |
News Archive
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
New research has found that modern lifestyle habits may play a bigger role than food alone, when it comes to tooth decay.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
During her three-year battle with breast cancer, my wife, Leslie, graciously endured multiple rounds of horrifically toxic treatment to eke out more time with our two young children.
Rickets is a disease of the growing bones among children that is caused due to deficiency of Vitamin D mainly due to lack of sunlight exposure. It was most commonly seen during the Victorian era due to smog and lack of exposure to sunlight among the children in the cities
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 93.2 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 72.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 72.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 80.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.2 | 93.3 |
News Archive
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
New research has found that modern lifestyle habits may play a bigger role than food alone, when it comes to tooth decay.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
During her three-year battle with breast cancer, my wife, Leslie, graciously endured multiple rounds of horrifically toxic treatment to eke out more time with our two young children.
Rickets is a disease of the growing bones among children that is caused due to deficiency of Vitamin D mainly due to lack of sunlight exposure. It was most commonly seen during the Victorian era due to smog and lack of exposure to sunlight among the children in the cities
› Verified 3 days ago
| Home Health Aides | 9 |
| Counselors | 2 |
| Homemakers | 1 |
| Medical Social Workers | 3 |
| Physicians | 1 |
| Registered Nurses | 12 |
| Other Personnel | 9 |
| Total Employees | 37 |
|---|
News Archive
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
New research has found that modern lifestyle habits may play a bigger role than food alone, when it comes to tooth decay.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
During her three-year battle with breast cancer, my wife, Leslie, graciously endured multiple rounds of horrifically toxic treatment to eke out more time with our two young children.
Rickets is a disease of the growing bones among children that is caused due to deficiency of Vitamin D mainly due to lack of sunlight exposure. It was most commonly seen during the Victorian era due to smog and lack of exposure to sunlight among the children in the cities
› Verified 3 days ago
| Hospice Of Kona Location: 75-5925 Walua Road, Suite 101, Kailua Kona, Hawaii, 96740 Phone: (808) 324-7700 |